Liver Cancer Trial, Recruiting (NCT06345508)

Liver Cancer Trial, Recruiting NCT06345508 Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06345508 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults who are already scheduled as part of their regular medical care to have ultrasound or MRI scans to monitor for liver cancer (HCC), or to have an MRI scan to get a closer look at a nodule (small growth) found on the liver.

Who may not be able to join:

People who have already received treatment directed at the liver (such as ablation or radiation to the liver) or treatment that affects the whole body (such as chemotherapy or targeted drug therapy) for their condition.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06345508

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

More information: https://clinicaltrials.gov/study/NCT06345508

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults who are already scheduled as part of their regular medical care to have ultrasound or MRI scans to monitor for liver cancer (HCC), or to have an MRI scan to get a closer look at a nodule (small growth) found on the liver.

Who may not be able to join:

People who have already received treatment directed at the liver (such as ablation or radiation to the liver) or treatment that affects the whole body (such as chemotherapy or targeted drug therapy) for their condition.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Registry

ClinicalTrials.gov

Start date

20 August 2024

Est. completion

1 June 2029

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Compare the sensitivity of QUS + B-mode US vs B-mode US alone for lesion detection, using MRI as the reference standard for detection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov